Global Child Health

  • Research Faculty

  • Show All

    Director

    A photo of Mark Steinhoff.

    Mark C. Steinhoff, MD Director, Global Health Center

    is interested in the broad effects of immunization in prevention of illness both in US and low-resource regions. The Mother’s Gift project of antenatal maternal immunization with influenza vaccine showed protection of mothers and their unvaccinated infants, as well as increased birth weights of the newborns. His team is currently evaluating antenatal influenza vaccine in 3,600 pregnant women in S. Asia to assess the broader effects of prevention of influenza. In Cincinnati, they are evaluating the safety and immunogenicity of influenza vaccines provided to mothers after delivery. They are also carrying out a prospective antepartum influenza vaccine study to assess the differences in immune response between healthy pregnant and nonpregnant women.

    513-636-1376
    mark.steinhoff@cchmc.org

    Mark C. Steinhoff, MD

    Director, Global Health Center

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-1376

    Fax: 513-803-0903

    Email: mark.steinhoff@cchmc.org

    Show All

    Education and Training

    MD: University of Chicago, Chicago, Illinois, 1973.

    Residency and Chief Residency: Pediatrics, University of Rochester Medical Center, Rochester, New York.

    Fellowship, Infectious Diseases: University of Rochester Medical Center, Rochester, New York.

    Certification: New York State Medical License, 1976; Pediatrics, 1978; Tamil Nadu Medical Council (India), 1980; Michigan Medical License, 1985; Maryland Medical License, 1986; Ohio Medical License, 2010; Pediatric Infectious Diseases Society, 1988.

    Publications

    View PubMed Publications

    Faculty

    No photo available

    Steven Black, MD

    is focusing on the evaluation of vaccine safety, vaccine efficacy and the epidemiology of vaccine preventable diseases in the United States but especially in the developing world. He is interested in fostering collaborative efforts to improve vaccine safety and effectiveness assessment in low and middle income countries.

    513-803-0747
    steven.black1@cchmc.org

    Steven Black, MD

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-803-0747

    Fax: 513-803-0903

    Email: steven.black1@cchmc.org

    Show All

    Specialties

    Vaccine safety and the use of computerized data to evaluate vaccines in the developed and developing world; vaccine clinical trials

    Education and Training

    MD: University of California, San Diego, 1973

    Residency: Pediatrics, Kaiser Hospital, San Fransisco CA; Infectious Disease, University of California, San Fransisco CA

    Certification: Pediatrics, 1980; Pediatric Infectious Diseases, 1995

    Publications

    View PubMed Publications
    A photo of Dr. Adekunle Dawodu.

    Adekunle H. Dawodu, MBBS, FRCPCH Director, International Patient Care and Education

    is focusing on perinatal and pediatric vitamin D nutrition. His current research focuses on the study of the efficacy and safety of high dose vitamin D supplementation to prevent vitamin D deficiency in pregnant Arab mothers and their newborn infants. 

    513-636-1966
    adekunle.dawodu@cchmc.org

    Adekunle H. Dawodu, MBBS, FRCPCH

    Director, International Patient Care and Education

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-1966

    Fax: 513-803-0903

    Email: adekunle.dawodu@cchmc.org

    Show All

    Specialties

    International child health; neonatology; perinatal epidemiology; perinatal and pediatric vitamin D and calcium metabolism

    Education and Training

    MBBS: University of Ibadan Medical School, Ibadan, Nigeria, 1968.

    DTCH: University of Liverpool, Liverpool, England, 1973.

    Fellowship: Neonatology, University of Cincinnati, Cincinnati, OH, 1977.

    Publications

    View PubMed Publications
    A photo of Cinnamon Dixon.

    Cinnamon A. Dixon, DO, MPH

    is a research faculty dually appointed in the Divisions of Emergency Medicine and Global Health. Her research interests include global pediatric injury prevention and trauma care, and dog bite prevention. Her current projects include the development and testing of a novel intervention for child safety utilizing multimedia technology, and pediatric trauma epidemiology in Campinas, Brazil.

    513-736-7966
    cinnamon.dixon@cchmc.org

    Cinnamon A. Dixon, DO, MPH

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-736-7966

    Email: cinnamon.dixon@cchmc.org

    Show All

    Specialties

    Pediatric injury prevention; global health injury prevention and trauma care; dog bite prevention

    Biography

    Cinnamon Dixon, DO, MPH, is a research faculty dually appointed in the Divisions of Emergency Medicine and Global Health.  Her research interests include global pediatric injury prevention and trauma care, and dog bite prevention.  Her current projects include the development and testing of a novel intervention for child safety utilizing multimedia technology, and pediatric trauma epidemiology in Campinas, Brazil.

    Dr. Dixon is a consultant for the World Health Organization (WHO) Department of Violence and Injury Prevention where she has co-lead/authored multiple global injury prevention factsheets and teaching modules. She is the lead coordinator and author for the Global Child Injury Module for the American Academy of Pediatrics Global Child Health Education Modules Project.  Dr. Dixon was former intern at the WHO and a Columbia University Mailman School of Public Health, Systems Improvement at District Hospitals and Regional Training of Emergency Care in Ghana scholarship awardee.

    Dr. Dixon has authored several original manuscripts and books chapters, and speaks regularly at national and international conferences regarding her work and the need for increased global child injury prevention.

    Education and Training

    BS: University of Colorado, Denver, CO, 1998.

    DO: Kirksville College of Osteopathic Medicine, Kirksville, MO, 2004.

    Residency: Pediatrics, Children's Mercy Hospital, Kansas City, MO, 2007.

    Certification: Pediatrics, 2007; Pediatric Emergency Medicine, 2013.

    Fellowship: Pediatric Emergency Medicine and Global Health Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2010.

    Master of Public Health: University of Cincinnati, Cincinnati, OH, 2010.

    Internship: Violence and Injury Prevention, World Health Organization, Geneva, 2010.

    Publications

    A photo of Russell Ware.

    Russell E. Ware, MD, PhD Director, Division of Hematology

    is a recognized expert in sickle cell disease. He is the national PI for several NHLBI-funded sickle cell clinical trials, and has recently begun an international program to improve the diagnosis, treatment, and research for sickle cell disease in developing countries. His laboratory focuses on genetic modifiers of sickle cell disease, as well as the pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea therapy.
    Visit the Ware Lab.

    513-636-4266
    russell.ware@cchmc.org

    Russell E. Ware, MD, PhD

    Director, Division of Hematology

    Marjory J. Johnson Chair of Hematology Translational Research, Division of Hematology

    Co-Executive Director, Cancer and Blood Diseases Institute

    Associate Director, Global Health Center

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Email: russell.ware@cchmc.org

    Show All

    Specialties

    Sickle cell disease; hemolytic anemia; immune-mediated cytopenia; PNH
    Visit the Ware Lab.

    Biography

    Russell Ware, MD, PhD, has been involved with a wide variety of clinical and translational hematology research projects for over 25 years, but his primary interests have focused on sickle cell disease. Dr. Ware has substantial personal experience with directing patient-oriented research, and he currently runs an NIH-funded laboratory effort that investigates genetic modifiers of sickle cell disease. The main focus of his lab research is to understand the phenotypic variability that occurs with hydroxyurea treatment, through the study of hydroxyurea pharmacokinetics, pharmacodynamics, pharmacogenetics, and pharmacogenomics. Dr. Ware is also the national Principal Investigator for several NIH-funded multicenter sickle cell clinical trials, including the recently completed Stroke With Transfusions Changing to Hydroxyurea (SWiTCH), and the current TCD With Transfusions Changing to Hydroxyurea (TWiTCH) and Sparing Conversion to Abnormal TCD Elevations (SCATE) studies that include non-US clinical sites. Most recently, Dr. Ware has moved his research efforts into the international arena, starting SCD pilot screening programs in Angola, and now conducting clinical trials to determine the safety and efficacy of hydroxyurea in developing countries.

    Education and Training

    MD: Duke University School of Medicine, Durham, NC, 1979-83.

    Residency: Baylor College of Medicine, Houston, TX, 1983-86.

    Fellowship: Duke Medical Center, Durham, NC, 1986-89.

    PhD: Duke University School of Medicine, Durham, NC, 1987-91.

    Certification: Pediatric Hematology/Oncology.

    Publications